MannKind Corp $8.41

down -0.25


31/7/2014 11:50 AM  |  NASDAQ : MNKD  
Industries : Drugs / Biotechnology
Get Trend Analysis Icon Get MNKD Trend Analysis - it has underperformed the S&P 500 by 0%

Partner Headlines

  1. Osiris Stem Cells To Compliment Mannkind's Afrezza In Disrupting Diabetes ...

    GuruFocus
  2. Mannkind Corporation: Safe Labeling, Incentivized Spirometry and Experts ...

    GuruFocus
  3. Mannkind Corporation: Why Afrezza Would Completely Dominate The Insulin ...

    GuruFocus
  4. A Look at Mannkind Corporation's True Value

    GuruFocus
  5. Morning Market Losers

    Benzinga
  6. Benzinga's Top #PreMarket Losers

    Benzinga
  7. UPDATE: MLV & Co. Downgrades MannKind On Fair Valuation

    Benzinga
  8. Markets Little Changed As The Quarter Comes To An End

    Benzinga
  9. General Motors Issues More Recalls, Reach 27 Million Autos Recalled In ...

    Benzinga
  10. MannKind Jumps On FDA Approval; Rayonier Shares Slide

    Benzinga
  11. RBC Looks For Post-Approval Data On MannKind

    Benzinga
  12. Markets Edge Higher; PPG To Acquire Comex For $2.3 Billion

    Benzinga
  13. Benzinga's Volume Movers

    Benzinga
  14. Stocks Hitting 52-Week Highs

    Benzinga
  15. Morning Market Movers

    Benzinga
  16. MannKind Shares See #PreMarket Spike Following FDA Approval

    Benzinga
  17. Benzinga's Top #PreMarket Gainers

    Benzinga
  18. Stocks To Watch For June 30, 2014

    Benzinga
  19. Regarding Afrezza, FDA Statement:

    Benzinga
  20. 6 Stocks That May Be Worth Buying Right Now

    Benzinga
  21. UPDATE: Piper Jaffray Upgrades MannKind After 'Busted' Call For Afrezza

    Benzinga
  22. Benzinga's Top #PreMarket Gainers

    Benzinga
  23. UPDATE: Brinson Patrick Initiates Coverage on MannKind

    Benzinga
  24. Benzinga's Top Initiations

    Benzinga
  25. Market Wrap For April 7: Bears In Complete Control As Markets Get Hammered ...

    Benzinga
  26. Mid-Day Market Update: Dow Tumbles Over 100 Points; Intel Shares Rise Following ...

    Benzinga
  27. MannKind: FDA Delays Afrezza Decision by Three Months

    FoxBusiness
  28. Mid-Morning Market Update: Markets Drop; Mallinckrodt To Acquire Questcor ...

    Benzinga
  29. Morning Market Losers

    Benzinga
  30. Benzinga's Top #PreMarket Losers

    Benzinga
  31. MannKind Announces FDA Extends PDUFA Date for AFREZZA By 3 Months

    Benzinga
  32. Morning Market Movers

    Benzinga
  33. Benzinga's Top #PreMarket Gainers

    Benzinga
  34. Mid-Afternoon Market Update: MannKind Hangs Onto its Gains as Yelp Shares ...

    Benzinga
  35. Piper Jaffray Not Convinced MannKind's Afreeza Will Be Commercial Success ...

    Benzinga
  36. Mid-Day Market Update: Apollo Drops After Q2 Results; MannKind Shares Spike ...

    Benzinga
  37. Mid-Morning Market Update: Markets Flat; Monsanto Earnings Beat Street ...

    Benzinga
  38. FDA Group Recommends Afrezza, MannKind Shares Rally 80%

    FoxBusiness
  39. Morning Market Movers

    Benzinga
  40. Benzinga's Top #PreMarket Gainers

    Benzinga
  41. Stocks To Watch For April 2, 2014

    Benzinga
  42. UPDATE: MannKind Confirms FDA Panel Recommends Approval of AFREZZA

    Benzinga
  43. Market Wrap For March 31: Stocks Rally As Yellen Confirms Support For Economy

    Benzinga
  44. Mid-Afternoon Market Update: American Capital Rises as MannKind Shares ...

    Benzinga
  45. Shares of MannKind Plummet Prior to Drug Advisory Meeting

    Benzinga
  46. FDA to Recommend Against MannKind's Afrezza, Stock Continues Slide

    Benzinga
  47. Morning Market Losers

    Benzinga
  48. Benzinga's Top #PreMarket Losers

    Benzinga
  49. Market Wrap For March 28: Markets Still Positive Despite Giving Up Early ...

    Benzinga
  50. Mannkind Shares Dip After FDA Group Raises Afrezza Concerns

    FoxBusiness
Trading Center